Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin

scientific article published on April 1, 2003

Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0301-472X(03)00006-7
P953full work available at URLhttp://www.exphem.org/article/S0301472X03000067/pdf
https://api.elsevier.com/content/article/PII:S0301472X03000067?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:S0301472X03000067?httpAccept=text/xml
P698PubMed publication ID12691916

P2093author name stringAnna Hitz
Erik Dwyer
Joan C. Egrie
Jeffrey K. Browne
Michele A. Lykos
P2860cites workCleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
Development and characterization of novel erythropoiesis stimulating protein (NESP)Q28362976
Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment mass spectrometryQ30404030
Erythropoietin: gene cloning, protein structure, and biological propertiesQ30405031
The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction.Q33632893
Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxideQ33645309
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trialQ34182887
Expression cloning of the murine erythropoietin receptorQ35416452
Anemia induces accumulation of erythropoietin mRNA in the kidney and liverQ36918011
The role of carbohydrate in recombinant human erythropoietinQ38341593
Studies on the Role of Sialic Acid in the Physical and Biological Properties of ErythropoietinQ38527406
Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietinsQ39104192
Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applicationsQ40513398
The erythropoietin receptor: biogenesis, dimerization, and intracellular signal transductionQ41124926
Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen.Q53420168
Inactivation of Erythropoietin by Neuraminidase and by Mild Substitution ReactionsQ58952216
Structural Analysis of the Sialylated N- and O-Linked Carbohydrate Chains of Recombinant Human Erythropoietin Expressed in Chinese Hamster Ovary Cells. Sialylation Patterns and Branch Location of Dimeric N-acetyllactosamine UnitsQ61994780
Characterization and biological effects of recombinant human erythropoietinQ68928759
Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trialQ69559204
Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysisQ69889300
The role of carbohydrate in erythropoietin actionQ70108503
Structures of mucin-type sugar chains on human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cellsQ70630459
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectcell biologyQ7141
geneticsQ7162
erythropoietinQ218706
darbepoetin alfaQ2178381
P304page(s)290-299
P577publication date2003-04-01
P1433published inExperimental HematologyQ5421109
P1476titleDarbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin
P478volume31